SUN.L
Surgical Innovations Group PLC
Price:  
0.65 
GBP
Volume:  
200,000.00
United Kingdom | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUN.L WACC - Weighted Average Cost of Capital

The WACC of Surgical Innovations Group PLC (SUN.L) is 9.3%.

The Cost of Equity of Surgical Innovations Group PLC (SUN.L) is 10.80%.
The Cost of Debt of Surgical Innovations Group PLC (SUN.L) is 5.50%.

Range Selected
Cost of equity 9.10% - 12.50% 10.80%
Tax rate 13.60% - 25.30% 19.45%
Cost of debt 4.00% - 7.00% 5.50%
WACC 7.8% - 10.8% 9.3%
WACC

SUN.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 0.85 1.07
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.10% 12.50%
Tax rate 13.60% 25.30%
Debt/Equity ratio 0.3 0.3
Cost of debt 4.00% 7.00%
After-tax WACC 7.8% 10.8%
Selected WACC 9.3%

SUN.L's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for SUN.L:

cost_of_equity (10.80%) = risk_free_rate (4.25%) + equity_risk_premium (6.50%) * adjusted_beta (0.85) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.